- Home
- TNFA vs LGHL Comparison
TNFA vs LGHL Comparison
Compare TNFA & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNFA
- LGHL
- Stock Information
- Founded
- TNFA 2014
- LGHL 2015
- Country
- TNFA United States
- LGHL Singapore
- Employees
- TNFA N/A
- LGHL N/A
- Industry
- TNFA
- LGHL Investment Bankers/Brokers/Service
- Sector
- TNFA
- LGHL Finance
- Exchange
- TNFA NYSE
- LGHL Nasdaq
- Market Cap
- TNFA 1.6M
- LGHL 1.5M
- IPO Year
- TNFA N/A
- LGHL N/A
- Fundamental
- Price
- TNFA $0.10
- LGHL $3.92
- Analyst Decision
- TNFA
- LGHL
- Analyst Count
- TNFA 0
- LGHL 0
- Target Price
- TNFA N/A
- LGHL N/A
- AVG Volume (30 Days)
- TNFA 4.6M
- LGHL 2.3M
- Earning Date
- TNFA 08-18-2025
- LGHL 07-22-2025
- Dividend Yield
- TNFA N/A
- LGHL N/A
- EPS Growth
- TNFA N/A
- LGHL N/A
- EPS
- TNFA N/A
- LGHL N/A
- Revenue
- TNFA N/A
- LGHL N/A
- Revenue This Year
- TNFA N/A
- LGHL N/A
- Revenue Next Year
- TNFA N/A
- LGHL N/A
- P/E Ratio
- TNFA N/A
- LGHL N/A
- Revenue Growth
- TNFA N/A
- LGHL N/A
- 52 Week Low
- TNFA $0.10
- LGHL $2.13
- 52 Week High
- TNFA $2.16
- LGHL $21.15
- Technical
- Relative Strength Index (RSI)
- TNFA 30.72
- LGHL 64.34
- Support Level
- TNFA $0.11
- LGHL $2.81
- Resistance Level
- TNFA $0.14
- LGHL $3.27
- Average True Range (ATR)
- TNFA 0.02
- LGHL 0.45
- MACD
- TNFA 0.00
- LGHL 0.11
- Stochastic Oscillator
- TNFA 3.64
- LGHL 83.36
About TNFA TNF PHARMACEUTICALS INC EFFEC
TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms, Isomyosamine and Supera-CBD. Isomyosamine is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B. The company has one reportable segment focused on Isomyosamine.
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.